- All sections
- A - Human necessities
- A61K - Preparations for medical, dental or toiletry purposes
- A61K 47/64 - Drug-peptide, drug-protein or drug-polyamino acid conjugates, i.e. the modifying agent being a peptide, protein or polyamino acid which is covalently bonded or complexed to a therapeutically active agent
Patent holdings for IPC class A61K 47/64
Total number of patents in this class: 5517
10-year publication summary
|
201
|
311
|
565
|
656
|
731
|
703
|
791
|
735
|
667
|
45
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| The Regents of the University of California | 19517 |
92 |
| Bicyclerd Limited | 138 |
67 |
| Glaxosmithkline Biologicals S.A. | 1696 |
58 |
| Mayo Foundation for Medical Education and Research | 3115 |
57 |
| Pfizer Inc. | 3368 |
51 |
| Sarepta Therapeutics, Inc. | 361 |
46 |
| Massachusetts Institute of Technology | 9913 |
45 |
| Yale University | 2289 |
45 |
| Purdue Research Foundation | 3477 |
41 |
| Bicycletx Limited | 167 |
38 |
| Bristol-myers Squibb Company | 4863 |
36 |
| The United States of America, as represented by the Secretary, Department of Health and Human Services | 2838 |
36 |
| The Board of Trustees of the Leland Stanford Junior University | 6246 |
34 |
| Northwestern University | 3276 |
32 |
| The Johns Hopkins University | 5533 |
31 |
| Ohio State Innovation Foundation | 1978 |
31 |
| Sapreme Technologies B.V. | 81 |
30 |
| President and Fellows of Harvard College | 5913 |
26 |
| Board of Regents, The University of Texas System | 5619 |
25 |
| Case Western Reserve University | 1770 |
23 |
| Other owners | 4673 |